Comparison of the safety and efficacy of the wild-type and lpxL/lpxM mutant inactivated vaccine against the avian pathogenic Escherichia coli O1, O2, and O78 challenge
- Resource Type
- Article
- Source
- In
Vaccine 11 April 2024 42(10):2707-2715 - Subject
- Language
- ISSN
- 0264-410X